DIRS.INFO The most relevant business & tech news

☆ Biden says he'll ban TikTok if Congress passes bill, but he's campaigning on it until then
▼ + stars: | 2024-03-08 | by ( Jonathan Vanian | In | ) www.cnbc.com time to read: +10 min

Nathan Howard | ReutersSince Biden's playful intro post, his campaign's TikTok account has notched over 222,000 followers and over 2.4 million likes. The Biden campaign didn't immediately respond to a request for comment. On the app, users were greeted with a screenshot warning them that Congress was "planning a total ban of TikTok." TikTok goes to WashingtonU.S. political campaigns more broadly are trying to figure out how best to utilize TikTok. Last April, for instance, the White House said it was enlisting a squad of volunteer TikTok and Instagram influencers to help spread awareness of the Biden campaign.

Persons: Jaap Arriens, Joe Biden, TikTok, Maggie Macdonald, Biden, Kansas City Chiefs —, Macdonald, China's ByteDance, Troy Balderson, Shou Zi Chew, Nathan Howard, Donald Trump, Aaron Earls, Biden's, Karine Jean, Pierre, didn't, influencers, it's, Kennedy, Earls, Marilyn Monroe, Joe DiMaggio, Anupam Chander, —, Vivek Ramaswamy, wouldn't, We've, we'll, Anish Mohanty, Mohanty, that's Organizations: Nurphoto, Kansas City Chiefs, University of Kentucky, Washington , D.C, U.S, Chinese Communist Party, CCP, CNBC, U.S . Capitol, Reuters, Republican, Democratic, Senate, White, Biden, Washington U.S, Facebook, Democratic National Committee, Climate Power, Georgetown University Law Center, Congress, Trump, TikTok, Republican Party Locations: Australia, Singapore, Mexico, Washington ,, U.S, Ohio, Washington , U.S, Washington, China, Gaza

☆ Photos: Ayodhya Ram Mandir temple inaugurated in consecration ceremony overseen by Modi
▼ + stars: | 2024-01-23 | by ( Rhea Mogul | ) edition.cnn.com time to read: +4 min

Crowds gather during the opening of a temple dedicated to Hindu deity Lord Ram, in Ayodhya, India, on January 22, 2024. Inside the sanctum sanctorum of the temple Monday, Modi presided over the Pran Pratishtha, or consecration ceremony, of an idol of Lord Ram, one of Hinduism’s most revered deities. Indian Prime Minister Narendra Modi plays a leading role in the ceremony consecrating a statue of the god Ram. “Today our Lord Ram has come. A man prays on the banks of Sarayu River on the occasion of Ram temple's consecration ceremony in Ayodhya on January 22, 2024.

Persons: Narendra Modi, Lord Ram, Rajesh Kumar Singh, –, Modi, Pran Pratishtha, Ram, Imtiyaz Khan, ” Modi, “ Ram, Money Sharma, Hinduism's Lord Ram, Amitabh Bachchan, Sachin Tendulkar, Mukesh Ambani, Anupam Kher, Beckham, ”, Ram Charan, Alia Bhatt, Ranbir Kapoor, Madhuri Dixit Nene, Katrina Kaif, Ayushmann Khurrana, Vicky Kaushal, Alia Bhatt Rajesh Kumar Singh Organizations: CNN, Indian, Anadolu, Getty Locations: Ayodhya, India, India's Uttar Pradesh, Sarayu, Babri

☆ Big Tech has long avoided responsibility for online content. Generative AI could end that.
▼ + stars: | 2023-12-18 | by ( Kali Hays | ) www.businessinsider.com time to read: +8 min

For decades, Big Tech companies have avoided responsibility for anything posted on their platforms. Generative AI is about to end this prized legal protection. Meta, Google, Microsoft, Amazon and even Apple have spent the last year rushing to roll out generative AI tools and models to compete with OpenAI. Generative AI models and tools, however, are developed, owned and operated by Big Tech companies. Otherwise, by creating generative AI tools and providing the outputs, Chander sees few ways a tech company will be able to refute its role in generative AI content.

Persons: Meta, Bard, Mark Zuckerberg, what's, Aziz Huq, Anupam Chander, Chander, Huq, they've, Jason Schultz, It's, Schultz, " Shultz, Kali Hays Organizations: Big Tech, Google, Microsoft, Apple, Facebook, Business, Meta, University of Chicago's Law School, Georgetown Law, Institute, Rebooting Social Media, Harvard University, NYU Law, Technology Law, Policy Clinic, Twitter Locations: khays@insider.com, @hayskali

☆ Past decade was the hottest on record as climate change ‘surged alarmingly,’ WMO reports
▼ + stars: | 2023-12-05 | by ( Laura Paddison | Brandon Miller | ) edition.cnn.com time to read: +4 min

CNN —The decade between 2011 and 2020 was the hottest on record for the planet’s land and oceans as the rate of climate change “surged alarmingly,” according to a new report from the World Meteorological Organization. This year is also expected to be the hottest year, after six straight months of record global temperatures. Scientists have said this year’s exceptional warmth is the result of the combined effects of El Niño and human-caused climate change, which is driven by planet-warming fossil fuel pollution. A separate analysis released Monday by the Global Carbon Project found that carbon pollution from fossil fuels is on track to set a new record in 2023 – 1.1% higher than 2022 levels. The WMO report comes partway through the UN-backed COP28 climate summit, on the day focused on energy and industry.

Persons: El, Petteri Taalas, ” Elena Manaenkova, Anupam Nath, –, ” Taalas, ”, Pierre Friedlingstein, Amy Cassidy Organizations: CNN, World Meteorological Organization, Global, Project, WMO, UN, EU, Copernicus, DG DEFIS, Reuters, El Niño, University of Exeter’s Global Systems Institute Locations: Dubai, India, China, US, EU, Mayong, Gauhati, Assam, Greater London, Antarctica, Paris, El, COP28

☆ Subrata Roy, ‘bad boy billionaire’ and chief of India’s Sahara Group, dies
▼ + stars: | 2023-11-14 | by ( Rhea Mogul | ) edition.cnn.com time to read: +2 min

CNN —Subrata Roy, the founder of Sahara, once one of India’s largest conglomerates, died on Tuesday, his company said in a statement. Roy died in a Mumbai hospital following “an extended battle with complications arising from metastatic malignancy, hypertension, and diabetes,” the statement said. It was founded by Roy in 1978 and operates in sectors including real estate, banking, manufacturing and media. Considered one of the country’s most flamboyant tycoons, Roy rubbed shoulders with the Indian elite, including Bollywood superstars and high-profile politicians. “Heartbroken to learn about the passing of Sahara Shri Subrata Roy,” former Indian Olympian PV Sindhu wrote on X, formerly known as Twitter.

Persons: CNN — Subrata Roy, Roy, ”, Subrata Roy, Anupam Kher, ” Roy Organizations: CNN, Indian national cricket team, Formula, Securities and Exchange Board of India, India’s, Reuters, Netflix, Bad, Sindhu Locations: Mumbai, Sahara India, London, New York, Sahara, Lucknow

☆ He lost his eye in a tiger attack — but Bhadai Tharu is still fighting to protect the king of the jungle
▼ + stars: | 2023-11-13 | by ( Rebecca Cairns | ) edition.cnn.com time to read: +7 min

But by the time Tharu was growing up in the 1970s, the tiger population had dwindled to just 20% of its peak. As an adult, he became involved in forest conservation and was committed to protecting their habitat. Similarly, the creation of artificial watering holes has also helped to disperse the tiger population and direct animals away from local communities. “It is crucial to prioritize community development, to ensure that communities become advocates for tiger conservation,” Paudel adds. Even as human-animal conflicts increase, Tharu says the local communities are happy to see the tiger population flourish.

Persons: Bhadai Tharu, Tharu, “, ” Tharu recommitted, Vijay Bedi, ”, Umesh Paudel, Paudel, Anupam Roy, iStockphoto, NTNC, ” Tharu Organizations: CNN, WWF, Trust for Nature Conservation, Parks, Nepalese Army Locations: Bardiya, Nepal, India, Asia, Tharu’s, Khata, Uttar Pradesh

☆ JPMorgan says controversial eye disease treatment can more than double this biopharma stock
▼ + stars: | 2023-10-06 | by ( Lisa Kailai Han | ) www.cnbc.com time to read: +1 min

A controversial eye treatment from Apellis can lead to sharp returns for investors, according to JPMorgan. The bank upgraded the biopharmaceutical stock to overweight from neutral and raised its price target to $81 from $60. The drug aims to treat an eye disease called geographic atrophy, which, according to the Syfovre website, affects about 1 million people. APLS YTD mountain Apellis ytd chart Analyst Anupam Rama believes that Apellis' overall pipeline has only been strengthened by recent approvals of Syfovre. The analyst noted that some physicians who had initially paused treatment of Syfovre have already begun to return to prescribing the injection.

Persons: Anupam Rama, Apellis, Rama, Michael Bloom Organizations: JPMorgan, ~$ Locations: 4Q

☆ The unlikely love affair between Australia and Bollywood
▼ + stars: | 2023-08-19 | by ( Lianne Kolirin | ) edition.cnn.com time to read: +11 min

CNN —It is the kind of unlikely love story that would make the scriptwriters of Asia’s biggest movie business proud. Film & Casting TempleHarman Baweja starred alongside Priyanka Chopra in “Love Story 2050,” shot in South Australia and released in 2008. “Australia realized that after ‘servicing’ Bollywood for over 13 years it was time to shift gears and move to collaboration with Indian cinema,” said Sharma. Salim MerchantChanging global appetiteOf no little importance is the growing audience for Bollywood productions in Australia. Anupam Sharma films for Australia's first ethnic reality show, "Bollywood Star," on SBS TV by WTFN.

Persons: Anthony Albanese, Narendra Modi, Tony Burke, “, ”, Anupam Sharma, Sharma, Feroz Khan –, “ Bollywood’s Clint Eastwood ” –, I’m, ’, “ Prem Aggan, Khan, Harman Baweja, Priyanka Chopra, Mike Rann, Baweja, Harry Baweja, Ajay Devgan, ” Sharma, Garth Davis, Dev Patel, Nicole Kidman, David Wenham, Weinstein, ” Brothers Salim, Sulaiman Merchant, “ UnIndian, Salim Merchant, Salim, Sulaiman, Mitu Bhowmick Lange, Bhowmick Lange “, ” Bhowmick Lange, Bhowmick Lange, La Trobe, Anupam, “ Everyone’s Organizations: CNN, Asia’s, Australian, Indian Film, of Melbourne, Sydney Opera House, Baweja Studios, “, Mumbai, –, ”, Co, “ Salaam, La Trobe University, La, SBS, WTFN Locations: Australia, Delhi, Brisbane, Sydney, Australian, Melbourne, India, Lake Gairdner, South Australia, Western Australia, “ Australia, ” Australia, Canada, China, Mumbai, Victoria, China Town

☆ India rice export ban, explained
▼ + stars: | 2023-08-03 | by ( Danielle Wiener-Bronner | ) edition.cnn.com time to read: +6 min

But for importers and loyal consumers of Indian-grown non-basmati varieties, the ban has been disruptive, including in the United States. Internationally, the ban is causing an upheaval in the market and could especially impact places that rely on Indian rice exports. “So we’re looking to have a really healthy, robust US rice crop.”The United States primarily imports specialty and fragrant rice, he said, like arborio rice used to make risotto; jasmine rice; basmati rice and other varieties. “We are completely dependent on non-basmati rice,” said Kiran Kumar Pola, director of Deccan Foods, an importer and distributor of non-basmati Indian rice that operates out of Arizona. “We at India Bazaar understand the concerns raised in light of the recent ban on Indian Non-Basmati Raw Rice,” the post reads.

Persons: We’ve, USA Rice, what’s, “, ”, Tanner Ehmke, Anupam Nath, Ehmke, Joseph Glauber, it’s, Glauber, El Niño, “ There’s, Peter Bachmann, Charles Hart, ” Rice, Rory Doyle, Kiran Kumar Pola, Sona Masoori, Kerala Matta, Rice Organizations: New, New York CNN, ” USA Rice Federation, ”, International Food Policy Research, International Food Policy Research Institute, USA Rice Federation, BMI, Bloomberg, Deccan Foods, Facebook Locations: New York, United States, USA, India, CoBank, Asia, ” India, Guwahati, Philippines, Malaysia, Vietnam, Southeast Asia, Nigeria, Ivory Coast, Senegal, West Africa, Pakistan, South Asia, California, Pace , Mississippi, Arizona, Kerala, South India, Pola, Dallas

Rare diseases treatment developer Travere Therapeutics has the potential for meaningful long-term value, according to JPMorgan. Analyst Anupam Rama initiated coverage on Travere with an overweight rating Friday. The December 2024 price target of $26 implies shares surging 66% from Thursday's close. Earlier this year, Filspari received accelerated approval from the U.S. Food and Drug Administration. The company is also awaiting regulatory feedback for pegtibatinase , which is designed to treat classical homocystinuria, a rare genetic metabolic disorder.

Persons: Anupam Rama, Filspari, Rama, — CNBC's Michael Bloom Organizations: Travere Therapeutics, JPMorgan, U.S . Food, Drug Administration Locations: Thursday's, U.S

☆ Do Younger or Older Doctors Get Better Results?
▼ + stars: | 2023-07-08 | by ( Anupam B. Jena | Christopher Worsham | ) www.wsj.com time to read: 1 min

Imagine you’ve been admitted to the hospital and you’re meeting the physician taking care of you for the first time. Who are you hoping walks through that door? Would you rather they be in their 50s with a good amount of gray hair, or in their 30s, just a few years out of residency?

Persons: you’ve

☆ Are Wine, Chocolate and Artificial Sweeteners Good for You? Nutrition Science Needs a Reboot. - The New York Times
▼ + stars: | 2023-06-19 | by ( Anupam B. Jena | Christopher M. Worsham | ) www.nytimes.com time to read: +2 min

Take the case of artificial sweeteners. Randomized studies — where people are randomly assigned to one treatment or another to ensure that no other factors interfere — are considered the gold standard. But randomized trials of sweeteners are often small and brief, which makes it hard to reach reliable conclusions about their long-term effects. The way sweeteners are studied in trials is also often very different from the way people use them in the real world. If people who consume more sweeteners are more likely to have Type 2 diabetes, did the sweeteners cause the diabetes?

☆ A drug company abandoned a treatment for ‘bubble boy disease.’ After a 5-year fight, this little girl is about to get it
▼ + stars: | 2023-04-27 | by ( Elizabeth Cohen Lauren Mascarenhas | Elizabeth Cohen | Lauren Mascarenhas | ) edition.cnn.com time to read: +29 min

The Sulacks weighed their options: Have a transplant with a match that was less than ideal – far less – or wait for gene therapy to become available. The news release didn’t say anything else about the SCID gene therapy. Or was the company abandoning its plans for SCID gene therapy altogether? In February, 2021, the parents of more than 20 children who were waiting for the gene therapy treatment, including the Sulacks, wrote a letter to Gaspar. Insurance companies have sometimes balked at paying for gene therapy, which is typically given in one treatment.

The lawsuit argued that YouTube's actions provided "material support" to Islamic State. Critics including Democratic President Joe Biden and his Republican predecessor Donald Trump have said Section 230 needs reform in light of the actions of social media companies in the decades since its enactment. Nitsana Darshan-Leitner, a lawyer representing the Gonzalez family, said social media companies, through automated and human means, can prevent militant groups from using their services. "There should be zero tolerance for terrorism on social media. Terror organizations are using social media as a tool that they never had before - and cannot do without."

☆ Adani Group hires banks to hold bond investor calls after market rout
▼ + stars: | 2023-02-15 | by ( Davide Barbuscia | ) www.reuters.com time to read: +3 min

NEW YORK, Feb 15 (Reuters) - India's Adani Group and two of its main subsidiaries caught up in a short-selling storm in recent weeks are to hold calls with bond investors on Feb. 16 and Feb. 21, according to a document seen by Reuters. The planned calls follow a long-awaited credit report issued by the Indian conglomerate earlier this week that said its companies faced no material refinancing risk, or near-term liquidity issues. According to the document sent to investors the call on Thursday for Adani Group will be attended by its Chief Financial Officer (CFO) Jugeshinder Singh and head of Group Corporate Finance Anupam Misra. An Adani Green Energy call also on Thursday will involve its CFO Phuntsok Wangyal, and an Adani Transmission call next week will be attended by its CFO Rohit Soni and CFO of Adani Electricity Kunjal Mehta. Rating agencies S&P Global and Moody's this month revised their outlooks to negative from stable for some of the group's companies, while index provider MSCI said it would cut the weightings of some Adani companies in its stock indexes.

Others, like China, have criticized the war without meaningfully reducing ties with Russia. The war prompted condemnation in the United Nations and saw Russia booted from the UN Human Rights Council. Beijing has walked a careful line since the invasion began, at times exhibiting impatience with Russia's war in Ukraine. Putin in September acknowledged that China had "questions and concerns" about the war while meeting with Xi in Uzbekistan. "Putin's allies are not 'turning on him,' only expressing dissatisfaction at the difficulties his war in Ukraine is causing them," he added.

☆ L'Oréal made a handheld, motorized device that helps people with disabilities apply lipstick. It's meant to give users independence.
▼ + stars: | 2023-01-05 | by ( Marguerite Ward | ) www.businessinsider.com time to read: +5 min

The makeup giant L'Oréal announced a handheld, computerized lipstick applicator. On Wednesday, at the annual Consumer Electronics Show in Las Vegas, L'Oréal unveiled a handheld, computerized makeup applicator called Hapta. Now, Balooch said the makeup world was approaching a revolution in technology that could help many with disabilities. Hapta is essentially a miniature robotic arm that helps users stabilize a tube and apply lipstick. L’OréalOver the past few years, Balooch said, L'Oréal engineers have been working to make the company's packaging easier to open for people with disabilities.

☆ This little-known pharma stock can rally more than 60% in 2023, JPMorgan says
▼ + stars: | 2023-01-03 | by ( Sarah Min | ) www.cnbc.com time to read: +2 min

A promising treatment for acute leukemia makes Syndax Pharmaceuticals an attractive stock, JPMorgan said. Analyst Anupam Rama initiated coverage of Syndax with an overweight rating ahead of what could be significant new data on the company's cancer therapy called revumenib. Shares of Syndax outperformed last year, rising more than 16%. The analyst's price target of $41 means the biotech stock could see another 61% increase from Friday's closing price. Additionally, the analyst is anticipating further data on another treatment for chronic graft-versus-host disease (cGVHD) called axatilimab in mid-2023.

Search resuls for: "Anupam"

18 mentions found